Stay updated with breaking news from Enavate Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
Immunome Inc (NASDAQ: IMNM) and Morphimmune have announced a merger agreement in
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
One of the most powerful fundraising tools a founder has is their pitch deck. But there are a few common mistakes that could ruin the whole thing.